Mediwound to present at upcoming investor conferences in february

Yavne, israel, feb. 14, 2022 (globe newswire) -- mediwound ltd. (nasdaq: mdwd), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that management would present at two upcoming investor conferences in february. details for each is as follows:
MDWD Ratings Summary
MDWD Quant Ranking